Evidence map›Paper›PMID 41927856›Full record

ArticleScientific reports2026

Integrated genomic and phenotypic characterization of antimicrobial resistance in Shiga toxin-producing Escherichia coli from asymptomatic carriers in Japan.

Yumi Imai, Miki Okuno, Shunsuke Iriguchi, Hiroshi Kaneko, Toshio Sato, Akio Noguchi, Takeshi Yamamoto, Yoshitoshi Ogura

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yumi ImaiDivision of Microbiology, Department of Infectious Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Miki OkunoDivision of Microbiology, Department of Infectious Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Shunsuke IriguchiDivision of Microbiology, Department of Infectious Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Hiroshi KanekoJapan Microbiological Laboratory, Miyagi, Japan.
Toshio SatoJapan Microbiological Laboratory, Miyagi, Japan.
Akio NoguchiJapan Microbiological Laboratory, Miyagi, Japan.
Takeshi YamamotoDivision of Microbiology, Department of Infectious Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Yoshitoshi OguraDivision of Microbiology, Department of Infectious Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan. y_ogura@kurume-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin-producing Escherichia coli (STEC) carried by asymptomatic individuals constitute an important reservoir for community transmission, but large-scale analyses of antimicrobial resistance (AMR) in carrier-derived STEC remain limited. In this study, to obtain fundamental information relevant to the eradication of STEC carriage, we analyzed 495 STEC strains isolated from stool-screened asymptomatic carriers in Japan. All the isolates had been previously subjected to whole-genome sequencing and were classified into more than 100 serotypes, predominantly O156:H25 (13.5%), O174:H21 (7.7%), and O105:H7 (6.1%). Genome-based analysis revealed at least one antimicrobial resistance gene (ARG) in 83 isolates (16.8%), with aph(3″)-Ib, aph(6)-Id, sul2, tet(A), and blaTEM-1 being the most prevalent. Most carrier-derived STEC belonged to phylogroup B1, whereas ARGs were identified in isolates from diverse phylogenetic lineages. Comparative analysis revealed that the AMR profiles of carrier-derived STEC were similar to those of human commensal E. coli, whereas cattle commensal isolates exhibited a higher ARG prevalence. Phenotypic susceptibility testing revealed that resistance to ampicillin (n = 33) and tetracycline (n = 50) was the most common, whereas resistance to fluoroquinolones (n = 1) was infrequent and no resistance was observed to fosfomycin (n = 0) or amikacin (n = 0). Together, these findings provide a comprehensive overview of AMR in STEC from asymptomatic carriers in Japan and support the continued effectiveness of several antimicrobial agents while underscoring the importance of ongoing genomic surveillance.

Indexed as

Carrier StateDrug Resistance, BacterialEscherichia coli InfectionsShiga-Toxigenic Escherichia coliAdultAnimalsAnti-Bacterial AgentsFecesFemaleGenome, BacterialGenomicsHumansJapanMaleMicrobial Sensitivity TestsPhenotypeAnti-Bacterial AgentsAntimicrobial resistanceAsymptomatic carrierGenomeShiga toxin-producing Escherichia coli

Identifiers

PMID41927856
PMCPMC13194739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.